The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling ...

This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

WASHINGTON — President Trump heralded a drug pricing agreement with Regeneron on Thursday, closing the last of 17 deals ...

Federal regulators are proposing a new, faster Medicare coverage pathway for medical devices deemed by the FDA as ...

Kennedy, a lawsuit challenging Kennedy’s attempts to remake the Advisory Committee on Immunization Practices. For the moment, ...

Friedrichs is a retired military medical officer whose last job in uniform was in the Pentagon as the senior medical adviser ...

The constant pressure that the heart is under from beating thousands of times a day may create an environment hostile to ...

Legislators in two states have resisted efforts to restrict Prescription Drug Affordability Boards, the controversial panels that are designed to function as rate-setting authorities and place limits ...

Kennedy Jr. once claimed there are no vaccines that are safe and effective. Yesterday, when a senator asked him if he ...

From my colleague Andrew Joseph: One of the open questions about the future of Sanofi as Belén Garijo takes over as CEO this ...

The promise of a better pan-RAS inhibitor Erasca has been described as the poor man’s Revolution Medicines. Impoverished ...

President Trump is reclassifying state-licensed medical marijuana as a less-dangerous drug, a major policy shift long sought ...